TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
公司代碼TXMD
公司名稱TherapeuticsMD Inc
上市日期Jan 31, 2001
CEOWalker (Marlan D)
員工數量1
證券類型Ordinary Share
年結日Jan 31
公司地址951 Yamato Road, Suite 220
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33431
電話15619611900
網址https://www.therapeuticsmd.com/
公司代碼TXMD
上市日期Jan 31, 2001
CEOWalker (Marlan D)